Inhibition of LDHA Deliver Potential Anticancer Performance in Renal Cell Carcinoma

Publisher： Karger

E-ISSN： 1423-0399|99|2|237-244

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.99, Iss.2, 2016-03, pp. : 237-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal Cell Carcinoma and Proteomics

By  

Urologia Internationalis, Vol. 84, Iss. 4, 2010-03 ,pp. : 373-377

Karger

Access to resources Recommend Favorite

Chromophobe Cell Renal Carcinoma

By  

Urologia Internationalis, Vol. 61, Iss. 3, 1999-02 ,pp. : 172-174

Karger

Access to resources Recommend Favorite

Immunotherapy of Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 63, Iss. 1, 1999-12 ,pp. : 16-21

Karger

Access to resources Recommend Favorite

Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 63, Iss. 1, 1999-12 ,pp. : 6-9

Karger

Access to resources Recommend Favorite

Metformin-Derived Growth Inhibition in Renal Cell Carcinoma Depends on miR-21-Mediated PTEN Expression

By  

Urologia Internationalis, Vol. 96, Iss. 1, 2016-0 ,pp. : 106-115

Karger

Access to resources Recommend Favorite